Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Douglas Ziedonis

    TitleProfessor
    SchoolUniversity of California, San Diego
    DepartmentPsychiatry
    Address9500 Gilman Drive #0602
    CA La Jolla 92093
    Phone858-534-5114
    vCardDownload vCard

      Collapse Research 
      Collapse Research Activities and Funding
      Treatment of Addiction to Nicotine in Schizophrenia
      NIH/NIDA R01DA015537Jul 5, 2003 - Jun 30, 2008
      Role: Co-Principal Investigator
      Modifying MET for use with ASI data
      NIH/NIDA R01DA015978Sep 25, 2002 - Jun 30, 2007
      Role: Principal Investigator
      THERAPY FOR DRUG ABUSERS WITH PSYCHIATRIC COMORBIDITY
      NIH/NIDA R01DA009127Sep 1, 1995 - Aug 31, 1999
      Role: Principal Investigator
      DRUG ABUSE AND PSYCHIATRIC COMORBIDITY
      NIH/NIDA K20DA000193Jul 1, 1993 - Jun 30, 1999
      Role: Principal Investigator

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Kim SS, Fang H, Bernstein K, Zhang Z, DiFranza J, Ziedonis D, Allison J. Acculturation, Depression, and Smoking Cessation: a trajectory pattern recognition approach. Tob Induc Dis. 2017; 15:33. PMID: 28747857.
        View in: PubMed
      2. Mitra S, Natarajan R, Ziedonis D, Fan X. Antioxidant and anti-inflammatory nutrient status, supplementation, and mechanisms in patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Aug 01; 78:1-11. PMID: 28499901.
        View in: PubMed
      3. Chen LS, Baker T, Brownson RC, Carney RM, Jorenby D, Hartz S, Smock N, Johnson M, Ziedonis D, Bierut LJ. Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives. Community Ment Health J. 2017 Aug; 53(6):695-702. PMID: 27900650.
        View in: PubMed
      4. Anderson ML, Wolf Craig KS, Ziedonis D. Barriers and Facilitators to Deaf Trauma Survivors' Help-Seeking Behavior: Lessons for Behavioral Clinical Trials Research. J Deaf Stud Deaf Educ. 2017 Jan; 22(1):118-130. PMID: 27881479.
        View in: PubMed
      5. Anderson ML, Wolf Craig KS, Ziedonis D. Deaf people's help-seeking following trauma: Experiences with and recommendations for the Massachusetts behavioral health care system. Psychol Trauma. 2017 Mar; 9(2):239-248. PMID: 27797568.
        View in: PubMed
      6. Ziedonis D, Larkin C, Appasani R. Dignity in mental health practice & research: Time to unite on innovation, outreach & education. Indian J Med Res. 2016 Oct; 144(4):491-495. PMID: 28256454.
        View in: PubMed
      7. Kim SS, Sitthisongkram S, Bernstein K, Fang H, Choi WS, Ziedonis D. A randomized controlled trial of a videoconferencing smoking cessation intervention for Korean American women: preliminary findings. Int J Womens Health. 2016; 8:453-62. PMID: 27660494; PMCID: PMC5019447.
      8. Gordon C, Gidugu V, Rogers ES, DeRonck J, Ziedonis D. Adapting Open Dialogue for Early-Onset Psychosis Into the U.S. Health Care Environment: A Feasibility Study. Psychiatr Serv. 2016 Nov 01; 67(11):1166-1168. PMID: 27417900.
        View in: PubMed
      9. Anderson ML, Wolf Craig KS, Hall WC, Ziedonis D. A Pilot Study of Deaf Trauma Survivors' Experiences: Early Traumas Unique to Being Deaf in a Hearing World. J Child Adolesc Trauma. 2016 Dec; 9(4):353-358. PMID: 28138351.
        View in: PubMed
      10. Das S, Tonelli M, Ziedonis D. Update on Smoking Cessation: E-Cigarettes, Emerging Tobacco Products Trends, and New Technology-Based Interventions. Curr Psychiatry Rep. 2016 May; 18(5):51. PMID: 27040275.
        View in: PubMed
      11. Byatt N, Levin LL, Ziedonis D, Moore Simas TA, Allison J. Enhancing Participation in Depression Care in Outpatient Perinatal Care Settings: A Systematic Review. Obstet Gynecol. 2015 Nov; 126(5):1048-58. PMID: 26444130; PMCID: PMC4618720 [Available on 11/01/16].
      12. Gonzalez G, DiGirolamo G, Romero-Gonzalez M, Smelson D, Ziedonis D, Kolodziej M. Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults. Drug Alcohol Depend. 2015 Nov 01; 156:243-53. PMID: 26454835; PMCID: PMC4652072 [Available on 11/01/16].
      13. Kim SS, Kim SH, Fang H, Kwon S, Shelley D, Ziedonis D. A Culturally Adapted Smoking Cessation Intervention for Korean Americans: A Mediating Effect of Perceived Family Norm Toward Quitting. J Immigr Minor Health. 2015 Aug; 17(4):1120-9. PMID: 24878686; PMCID: PMC4250475.
      14. Chung S, Kim SS, Kini N, Fang HJ, Kalman D, Ziedonis D. Smoking topography in Korean American and white men: preliminary findings. J Immigr Minor Health. 2015 Jun; 17(3):860-6. PMID: 24068611; PMCID: PMC3966984.
      15. Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy DN, Harrington A, Ziedonis D, Fan X, Zhao M. Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behav Brain Res. 2015 Aug 01; 289:78-83. PMID: 25920682; PMCID: PMC4441589.
      16. Wang X, Peng Z, Ziedonis D, Wang C, Yu B, Li T. Evaluation of tobacco use on Chinese population through ATTOC model: a cross-sectional survey on hospitalized psychiatric patients. Int J Clin Exp Med. 2015; 8(4):6008-15. PMID: 26131197; PMCID: PMC4483824.
      17. Li M, Deng W, He Z, Wang Q, Huang C, Jiang L, Gong Q, Ziedonis D, King JA, Ma X, Zhang N, Li T. A splitting brain: Imbalanced neural networks in schizophrenia. Psychiatry Res. 2015 May 30; 232(2):145-53. PMID: 25819347; PMCID: PMC4704446.
      18. Kelly MM, Sido H, Forsyth JP, Ziedonis D, Kalman D, Cooney JL. Acceptance and commitment therapy smoking cessation treatment for veterans with posttraumatic stress disorder: a pilot study. J Dual Diagn. 2015; 11(1):50-5. PMID: 25491589.
        View in: PubMed
      19. Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X. Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF. J Psychiatr Res. 2015 Jan; 60:22-8. PMID: 25282282.
        View in: PubMed
      20. Byron G, Ziedonis D, McGrath C, Frazier JA, deTorrijos F, Fulwiler C. Implementation of Mindfulness Training for Mental Health Staff: Organizational Context and Stakeholder Perspectives. Mindfulness (N Y). 2015 Aug; 6(4):861-872. PMID: 26500708.
        View in: PubMed
      21. Song X, Fan X, Zhang J, Zheng H, Li X, Pang L, Chen X, Zhang W, Harrington A, Ziedonis D, Lv L. Prolactin serum levels correlate with inflammatory status in drug-naïve first-episode schizophrenia. World J Biol Psychiatry. 2014 Sep; 15(7):546-52. PMID: 24959913.
        View in: PubMed
      22. Anderson ML, Ziedonis D, Najavits LM. Posttraumatic stress disorder and substance use disorder comorbidity among individuals with physical disabilities: findings from the National Comorbidity Survey Replication. J Trauma Stress. 2014 Apr; 27(2):182-91. PMID: 24659557.
        View in: PubMed
      23. Huang W, King JA, Ursprung WW, Zheng S, Zhang N, Kennedy DN, Ziedonis D, DiFranza JR. The development and expression of physical nicotine dependence corresponds to structural and functional alterations in the anterior cingulate-precuneus pathway. Brain Behav. 2014 May; 4(3):408-17. PMID: 24944870; PMCID: PMC4055191.
      24. Kim SS, Fang H, McKee SA, Ziedonis D. Prospective Evaluation of Factors Predicting Nicotine Withdrawal Symptoms Among Korean Americans. J Smok Cessat. 2014; 2014. PMID: 26413165.
        View in: PubMed
      25. Song X, Fan X, Li X, Zhang W, Gao J, Zhao J, Harrington A, Ziedonis D, Lv L. Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first-episode schizophrenia. Psychopharmacology (Berl). 2014 Jan; 231(2):319-25. PMID: 24337064.
        View in: PubMed
      26. Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L. Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight. Schizophr Res. 2013 Oct; 150(1):269-73. PMID: 23968860.
        View in: PubMed
      27. Byatt N, Biebel K, Friedman L, Debordes-Jackson G, Ziedonis D, Pbert L. Patient's views on depression care in obstetric settings: how do they compare to the views of perinatal health care professionals? Gen Hosp Psychiatry. 2013 Nov-Dec; 35(6):598-604. PMID: 23969144; PMCID: PMC4107904.
      28. Kim SS, Chung S, Park JI, Jung AJ, Kalman D, Ziedonis D. Smoking among individuals with schizophrenia in Korea: gender differences. Arch Psychiatr Nurs. 2013 Oct; 27(5):241-5. PMID: 24070993; PMCID: PMC3785671.
      29. Huang W, DiFranza JR, Kennedy DN, Zhang N, Ziedonis D, Ursprung S, King JA. Progressive levels of physical dependence to tobacco coincide with changes in the anterior cingulum bundle microstructure. PLoS One. 2013; 8(7):e67837. PMID: 23861816; PMCID: PMC3701580.
      30. Byatt N, Biebel K, Friedman L, Debordes-Jackson G, Ziedonis D. Women's perspectives on postpartum depression screening in pediatric settings: a preliminary study. Arch Womens Ment Health. 2013 Oct; 16(5):429-32. PMID: 23812739.
        View in: PubMed
      31. Byatt N, Biebel K, Debordes-Jackson G, Lundquist RS, Moore Simas TA, Weinreb L, Ziedonis D. Community mental health provider reluctance to provide pharmacotherapy may be a barrier to addressing perinatal depression: a preliminary study. Psychiatr Q. 2013 Jun; 84(2):169-74. PMID: 22941573.
        View in: PubMed
      32. Abar B, Baumann BM, Rosenbaum C, Boyer E, Ziedonis D, Boudreaux ED. Profiles of importance, readiness and confidence in quitting tobacco use. J Subst Use. 2013 Apr; 18(2):75-81. PMID: 26097430.
        View in: PubMed
      33. Byatt N, Simas TA, Lundquist RS, Johnson JV, Ziedonis D. Strategies for improving perinatal depression treatment in North American outpatient obstetric settings. J Psychosom Obstet Gynaecol. 2012 Dec; 33(4):143-61. PMID: 23194018.
        View in: PubMed
      34. Smelson D, Yu L, Buyske S, Gonzalez G, Tischfield J, Deutsch CK, Ziedonis D. Genetic association of GABA-A receptor alpha-2 and mu opioid receptor with cocaine cue-reactivity: evidence for inhibitory synaptic neurotransmission involvement in cocaine dependence. Am J Addict. 2012 Sep-Oct; 21(5):411-5. PMID: 22882391; PMCID: PMC3425941.
      35. Kim SS, Fang H, Difranza J, Ziedonis D, Ma GX. Gender Differences in the Fagerström Test for Nicotine Dependence in Korean Americans. J Smok Cessat. 2012 Aug 01; 7(1):1-6. PMID: 22936953.
        View in: PubMed
      36. Smelson D, Chen KW, Ziedonis D, Andes K, Lennox A, Callahan L, Rodrigues S, Eisenberg D. A pilot study of Qigong for reducing cocaine craving early in recovery. J Altern Complement Med. 2013 Feb; 19(2):97-101. PMID: 22757968; PMCID: PMC3576894.
      37. Pating DR, Miller MM, Goplerud E, Martin J, Ziedonis D. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr Clin North Am. 2012 Jun; 35(2):327-56. PMID: 22640759.
        View in: PubMed
      38. Kim SS, Kim SH, Ziedonis D. Tobacco dependence treatment for Korean Americans: preliminary findings. J Immigr Minor Health. 2012 Jun; 14(3):395-404. PMID: 21785963; PMCID: PMC3340485.
      39. Guydish J, Tajima B, Kulaga A, Zavala R, Brown LS, Bostrom A, Ziedonis D, Chan M. The New York policy on smoking in addiction treatment: findings after 1 year. Am J Public Health. 2012 May; 102(5):e17-25. PMID: 22420814; PMCID: PMC3340008.
      40. Boyer EW, Fletcher R, Fay RJ, Smelson D, Ziedonis D, Picard RW. Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol. 2012 Mar; 8(1):5-9. PMID: 22311668; PMCID: PMC3550228.
      41. Kim SS, Chen W, Kolodziej M, Wang X, Wang VJ, Ziedonis D. A systematic review of smoking cessation intervention studies in China. Nicotine Tob Res. 2012 Aug; 14(8):891-9. PMID: 22249687.
        View in: PubMed
      42. Guydish J, Ziedonis D, Tajima B, Seward G, Passalacqua E, Chan M, Delucchi K, Zammarelli L, Levy M, Kolodziej M, Brigham G. Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settings. Drug Alcohol Depend. 2012 Feb 1; 121(1-2):30-7. PMID: 21906892.
        View in: PubMed
      43. Wachholtz A, Gonzalez G, Boyer E, Naqvi ZN, Rosenbaum C, Ziedonis D. Intersection of chronic pain treatment and opioid analgesic misuse: causes, treatments, and policy strategies. Subst Abuse Rehabil. 2011; 2:145-62. PMID: 24474854; PMCID: PMC3846312.
      44. Wachholtz A, Ziedonis D, Gonzalez G. Comorbid pain and opioid addiction: psychosocial and pharmacological treatments. Subst Use Misuse. 2011; 46(12):1536-52. PMID: 21756033.
        View in: PubMed
      45. Ozhathil DK, Abar B, Baumann BM, Camargo CA, Ziedonis D, Boudreaux ED. The effect of removing cost as a barrier to treatment initiation with outpatient tobacco dependence clinics among emergency department patients. Acad Emerg Med. 2011 Jun; 18(6):662-4. PMID: 21518096; PMCID: PMC3777236.
      46. Boudreaux ED, Moon S, Baumann BM, Camargo CA, O'Hea E, Ziedonis D. Intentions to quit smoking: causal attribution, perceived illness severity, and event-related fear during an acute health event. Ann Behav Med. 2010 Dec; 40(3):350-5. PMID: 20827518; PMCID: PMC3532886.
      47. Guydish J, Tajima B, Chan M, Delucchi KL, Ziedonis D. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. Drug Alcohol Depend. 2011 Apr 01; 114(2-3):237-41. PMID: 21055884; PMCID: PMC3062722.
      48. Smelson D, Kalman D, Losonczy MF, Kline A, Sambamoorthi U, Hill LS, Castles-Fonseca K, Ziedonis D. A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J. 2012 Apr; 48(2):127-32. PMID: 20859765.
        View in: PubMed
      49. Chen KW, Comerford A, Shinnick P, Ziedonis D. Introducing qigong meditation into residential addiction treatment: a pilot study where gender makes a difference. J Altern Complement Med. 2010 Aug; 16(8):875-82. PMID: 20649456.
        View in: PubMed
      50. Boyer EW, Smelson D, Fletcher R, Ziedonis D, Picard RW. Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol. 2010 Jun; 6(2):212-6. PMID: 20623215; PMCID: PMC3550304.
      51. Williams JM, Steinberg ML, Zimmermann MH, Gandhi KK, Stipelman B, Budsock PD, Ziedonis D. Comparison of two intensities of tobacco dependence counseling in schizophrenia and schizoaffective disorder. J Subst Abuse Treat. 2010 Jun; 38(4):384-93. PMID: 20363089; PMCID: PMC2859987.
      52. Kalman D, Kim S, DiGirolamo G, Smelson D, Ziedonis D. Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev. 2010 Feb; 30(1):12-24. PMID: 19748166; PMCID: PMC2826972.
      53. DiFranza J, Ursprung WW, Lauzon B, Bancej C, Wellman RJ, Ziedonis D, Kim SS, Gervais A, Meltzer B, McKay CE, O'Loughlin J, Okoli CT, Fortuna LR, Tremblay M. A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict Behav. 2010 May; 35(5):373-82. PMID: 20056335.
        View in: PubMed
      54. George TP, Ziedonis D. Addressing tobacco dependence in psychiatric practice: promises and pitfalls. Can J Psychiatry. 2009 Jun; 54(6):353-5. PMID: 19527555.
        View in: PubMed
      55. Boudreaux ED, Baumann BM, Perry J, Marks D, Francies S, Camargo CA, Ziedonis D. Emergency department initiated treatments for tobacco (EDITT): a pilot study. Ann Behav Med. 2008 Dec; 36(3):314-25. PMID: 19050988.
        View in: PubMed
      56. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008 Dec; 10(12):1691-715. PMID: 19023823.
        View in: PubMed
      57. Ziedonis D, Amass L, Steinberg M, Woody G, Krejci J, Annon JJ, Cohen AJ, Waite-O'Brien N, Stine SM, McCarty D, Reid MS, Brown LS, Maslansky R, Winhusen T, Babcock D, Brigham G, Muir J, Orr D, Buchan BJ, Horton T, Ling W. Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependence. Drug Alcohol Depend. 2009 Jan 01; 99(1-3):28-36. PMID: 18805656; PMCID: PMC2770269.
      58. Ross S, Cidambi I, Dermatis H, Weinstein J, Ziedonis D, Roth S, Galanter M. Music therapy: a novel motivational approach for dually diagnosed patients. J Addict Dis. 2008; 27(1):41-53. PMID: 18551887.
        View in: PubMed
      59. Ziedonis D, Zammarelli L, Seward G, Oliver K, Guydish J, Hobart M, Meltzer B. Addressing tobacco use through organizational change: a case study of an addiction treatment organization. J Psychoactive Drugs. 2007 Dec; 39(4):451-9. PMID: 18303702; PMCID: PMC2981503.
      60. Huang FY, Ziedonis D, Hu HM, Kline A. Using information technology to evaluate the detection of co-occurring substance use disorders amongst patients in a state mental health system: implications for co-occurring disorder state initiatives. Community Ment Health J. 2008 Feb; 44(1):11-27. PMID: 17690982.
        View in: PubMed
      61. Williams JM, Gandhi KK, Steinberg ML, Foulds J, Ziedonis D, Benowitz NL. Higher nicotine and carbon monoxide levels in menthol cigarette smokers with and without schizophrenia. Nicotine Tob Res. 2007 Aug; 9(8):873-81. PMID: 17654300.
        View in: PubMed
      62. Boudreaux ED, Baumann BM, Camargo CA, O'Hea E, Ziedonis D. Changes in smoking associated with an acute health event: theoretical and practical implications. Ann Behav Med. 2007 Apr; 33(2):189-99. PMID: 17447871.
        View in: PubMed
      63. Kleber HD, Weiss RD, Anton RF, George TP, Greenfield SF, Kosten TR, O'Brien CP, Rounsaville BJ, Strain EC, Ziedonis D, Hennessy G, Connery HS, McIntyre JS, Charles SC, Anzia DJ, Cook IA, Finnerty MT, Johnson BR, Nininger JE, Summergrad P, Woods SM, Yager J, Pyles R, Cross CD, Peele R, Shemo JP, Lurie L, Walker RD, Barnovitz MA, Gray SH, Saxena S, Tonnu T, Kunkle R, Albert AB, Fochtmann LJ, Hart C, Regier D. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry. 2007 Apr; 164(4 Suppl):5-123. PMID: 17569411.
        View in: PubMed
      64. Kim SS, Ziedonis D, Chen KW. Tobacco use and dependence in Asian Americans: a review of the literature. Nicotine Tob Res. 2007 Feb; 9(2):169-84. PMID: 17365748.
        View in: PubMed
      65. Kim SS, Ziedonis D, Chen K. Tobacco use and dependence in Asian American and Pacific Islander adolescents: a review of the literature. J Ethn Subst Abuse. 2007; 6(3-4):113-42. PMID: 19842309.
        View in: PubMed
      66. Steinberg ML, Krejci JA, Collett K, Brandon TH, Ziedonis D, Chen K. Relationship between self-reported task persistence and history of quitting smoking, plans for quitting smoking, and current smoking status in adolescents. Addict Behav. 2007 Jul; 32(7):1451-60. PMID: 17125931; PMCID: PMC2398683.
      67. Hu HM, Kline A, Huang FY, Ziedonis D. Detection of co-occurring mental illness among adult patients in the New Jersey substance abuse treatment system. Am J Public Health. 2006 Oct; 96(10):1785-93. PMID: 17008574; PMCID: PMC1586138.
      68. Fuller BE, Guydish J, Tsoh J, Reid MS, Resnick M, Zammarelli L, Ziedonis D, Sears C, McCarty D. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. J Subst Abuse Treat. 2007 Jan; 32(1):53-60. PMID: 17175398; PMCID: PMC3496385.
      69. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006 Aug; 163(8 Suppl):5-82. PMID: 16981488.
        View in: PubMed
      70. Ziedonis D, Haberstroh S, Hanos Zimmermann M, Miceli M, Foulds J. Adolescent tobacco use and dependence: assessment and treatment strategies. Adolesc Med Clin. 2006 Jun; 17(2):381-410. PMID: 16814699.
        View in: PubMed
      71. Williams JM, Ziedonis D. Snuffing out tobacco dependence. Ten reasons behavioral health providers need to be involved. Behav Healthc. 2006 May; 26(5):27-31. PMID: 16736916.
        View in: PubMed
      72. Yanos PT, Ziedonis D. The patient-oriented clinician-researcher: advantages and challenges of being a double agent. Psychiatr Serv. 2006 Feb; 57(2):249-53. PMID: 16452704; PMCID: PMC1383049.
      73. Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M. The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report. J Clin Psychopharmacol. 2006 Feb; 26(1):9-12. PMID: 16415698.
        View in: PubMed
      74. Foulds J, Steinberg MB, Williams JM, Ziedonis D. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev. 2006 Jan; 25(1):59-71. PMID: 16492578.
        View in: PubMed
      75. Ziedonis D, Guydish J, Williams J, Steinberg M, Foulds J. Barriers and solutions to addressing tobacco dependence in addiction treatment programs. Alcohol Res Health. 2006; 29(3):228-35. PMID: 17373414.
        View in: PubMed
      76. Foulds J, Williams J, Order-Connors B, Edwards N, Dwyer M, Kline A, Ziedonis D. Integrating tobacco dependence treatment and tobacco-free standards into addiction treatment: New Jersey's experience. Alcohol Res Health. 2006; 29(3):236-40. PMID: 17373415.
        View in: PubMed
      77. Sussner BD, Smelson DA, Rodrigues S, Kline A, Losonczy M, Ziedonis D. The validity and reliability of a brief measure of cocaine craving. Drug Alcohol Depend. 2006 Jul 27; 83(3):233-7. PMID: 16384655.
        View in: PubMed
      78. Walters ST, Matson SA, Baer JS, Ziedonis D. Effectiveness of workshop training for psychosocial addiction treatments: a systematic review. J Subst Abuse Treat. 2005 Dec; 29(4):283-93. PMID: 16311181.
        View in: PubMed
      79. Ling W, Amass L, Shoptaw S, Annon JJ, Hillhouse M, Babcock D, Brigham G, Harrer J, Reid M, Muir J, Buchan B, Orr D, Woody G, Krejci J, Ziedonis D. A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction. 2005 Aug; 100(8):1090-100. PMID: 16042639; PMCID: PMC1480367.
      80. Williams JM, Ziedonis D, Abanyie F, Steinberg ML, Foulds J, Benowitz NL. Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect. Schizophr Res. 2005 Nov 15; 79(2-3):323-35. PMID: 15961287.
        View in: PubMed
      81. Williams JM, Foulds J, Dwyer M, Order-Connors B, Springer M, Gadde P, Ziedonis D. The integration of tobacco dependence treatment and tobacco-free standards into residential addictions treatment in New Jersey. J Subst Abuse Treat. 2005 Jun; 28(4):331-40. PMID: 15925267.
        View in: PubMed
      82. Boudreaux ED, Baumann BM, Friedman K, Ziedonis D. Smoking stage of change and interest in an emergency department-based intervention. Acad Emerg Med. 2005 Mar; 12(3):211-8. PMID: 15741583.
        View in: PubMed
      83. Steinberg ML, Williams JM, Steinberg HR, Krejci JA, Ziedonis D. Applicability of the Fagerström Test for Nicotine Dependence in smokers with schizophrenia. Addict Behav. 2005 Jan; 30(1):49-59. PMID: 15561448.
        View in: PubMed
      84. Ziedonis D. Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr. 2004 Dec; 9(12):892-904, 925. PMID: 15618940.
        View in: PubMed
      85. Williams JM, Ziedonis D, Foulds J. A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv. 2004 Sep; 55(9):1064-6. PMID: 15345771.
        View in: PubMed
      86. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav. 2004 Aug; 29(6):1067-83. PMID: 15236808.
        View in: PubMed
      87. Steinberg ML, Ziedonis D, Krejci JA, Brandon TH. Motivational interviewing with personalized feedback: a brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. J Consult Clin Psychol. 2004 Aug; 72(4):723-8. PMID: 15301657.
        View in: PubMed
      88. Smelson DA, Williams J, Ziedonis D, Sussner BD, Losonczy MF, Engelhart C, Kaune M. A double-blind placebo-controlled pilot study of risperidone for decreasing cue-elicited craving in recently withdrawn cocaine dependent patients. J Subst Abuse Treat. 2004 Jul; 27(1):45-9. PMID: 15223093.
        View in: PubMed
      89. Steinberg ML, Williams JM, Ziedonis D. Financial implications of cigarette smoking among individuals with schizophrenia. Tob Control. 2004 Jun; 13(2):206. PMID: 15175544; PMCID: PMC1747846.
      90. Foulds J, Burke M, Steinberg M, Williams JM, Ziedonis D. Advances in pharmacotherapy for tobacco dependence. Expert Opin Emerg Drugs. 2004 May; 9(1):39-53. PMID: 15155135.
        View in: PubMed
      91. Amass L, Ling W, Freese TE, Reiber C, Annon JJ, Cohen AJ, McCarty D, Reid MS, Brown LS, Clark C, Ziedonis D, Krejci J, Stine S, Winhusen T, Brigham G, Babcock D, Muir JA, Buchan BJ, Horton T. Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience. Am J Addict. 2004; 13 Suppl 1:S42-66. PMID: 15204675; PMCID: PMC1255908.
      92. Krejci J, Steinberg ML, Ziedonis D. Smoking status and substance abuse severity in a residential treatment sample. Drug Alcohol Depend. 2003 Dec 11; 72(3):249-54. PMID: 14643941.
        View in: PubMed
      93. Kampov-Polevoy AB, Ziedonis D, Steinberg ML, Pinsky I, Krejci J, Eick C, Boland G, Khalitov E, Crews FT. Association between sweet preference and paternal history of alcoholism in psychiatric and substance abuse patients. Alcohol Clin Exp Res. 2003 Dec; 27(12):1929-36. PMID: 14691380.
        View in: PubMed
      94. Ziedonis D, Williams JM, Smelson D. Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci. 2003 Oct; 326(4):223-30. PMID: 14557739.
        View in: PubMed
      95. Williams J, Ziedonis D. Naltrexone-bupropion combination therapy for protracted abstinence dysphoria. Am J Addict. 2003 May-Jun; 12(3):270-2. PMID: 12851023.
        View in: PubMed
      96. Smelson DA, Davis CW, Eisenstein N, Engelhart C, Williams J, Losonczy MF, Ziedonis D. Cognitive disparity in schizophrenics with and without cocaine dependency. J Subst Abuse Treat. 2003 Jan; 24(1):75-9. PMID: 12646333.
        View in: PubMed
      97. Smelson DA, Losonczy MF, Kilker C, Starosta A, Kind J, Williams J, Ziedonis D. An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv. 2002 Dec; 53(12):1612-6. PMID: 12461224.
        View in: PubMed
      98. Roeloffs CA, Wells KB, Ziedonis D, Tang L, Unützer J. Problem substance use among depressed patients in managed primary care. Psychosomatics. 2002 Sep-Oct; 43(5):405-12. PMID: 12297610.
        View in: PubMed
      99. Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D. Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry. 2002 Sep; 47(7):671-5. PMID: 12355680.
        View in: PubMed
      100. Brewster T, Farentinos C, Ziedonis D. Response: implementing motivational stepped care. Sci Pract Perspect. 2002 Jul; 1(1):47-8. PMID: 18567966; PMCID: PMC2851055.
      101. Brewster T, Farentinos C, Ziedonis D. Response: the neurobiological model in community treatment programs. Sci Pract Perspect. 2002 Jul; 1(1):21. PMID: 18567960; PMCID: PMC2851057.
      102. Smelson DA, Davis CW, Di Pano R, Johnson V, Losonczy MF, Ziedonis D. Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis. 2002 Mar; 190(3):200-2. PMID: 11923656.
        View in: PubMed
      103. Krejci J, Ziedonis D. Medications in the treatment of addiction: workplace issues. Occup Med. 2002 Jan-Mar; 17(1):91-104, v. PMID: 11726339.
        View in: PubMed
      104. Carol G, Smelson DA, Losonczy MF, Ziedonis D. Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv. 2001 Aug; 52(8):1029-31. PMID: 11474045.
        View in: PubMed
      105. George TP, Ziedonis D, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000 Nov; 157(11):1835-42. PMID: 11058482.
        View in: PubMed
      106. Woods SW, Ziedonis D, Sernyak MJ, Diaz E, Rosenheck RA. Characteristics of participants and nonparticipants in medication trials for treatment of schizophrenia. Psychiatr Serv. 2000 Jan; 51(1):79-84. PMID: 10647137.
        View in: PubMed
      107. Kraus ML, Ziedonis D, Feinberg MA, Segal SR, Israel L, Kraus MC. A community hospital's ambulatory addiction medicine program. Conn Med. 1998 Feb; 62(2):89-93. PMID: 9542290.
        View in: PubMed
      108. Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry. 1997 Aug; 54(8):713-20. PMID: 9283506.
        View in: PubMed
      109. Ziedonis D, Brady K. Dual diagnosis in primary care. Detecting and treating both the addiction and mental illness. Med Clin North Am. 1997 Jul; 81(4):1017-36. PMID: 9222266.
        View in: PubMed
      110. Kosten TR, Ziedonis D. Substance abuse and schizophrenia: editors' introduction. Schizophr Bull. 1997; 23(2):181-6. PMID: 9165628.
        View in: PubMed
      111. Ziedonis D, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull. 1997; 23(2):247-54. PMID: 9165635.
        View in: PubMed
      112. Ziedonis D, Trudeau K. Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull. 1997; 23(2):229-38. PMID: 9165633.
        View in: PubMed
      113. Farren CK, Clare AW, Ziedonis D, Hammeedi FA, Dinan TG. Evidence for reduced dopamine D2 receptor sensitivity in postwithdrawal alcoholics. Alcohol Clin Exp Res. 1995 Dec; 19(6):1520-4. PMID: 8749820.
        View in: PubMed
      114. Farren CK, Ziedonis D, Clare AW, Hammeedi FA, Dinan TG. D-fenfluramine-induced prolactin responses in postwithdrawal alcoholics and controls. Alcohol Clin Exp Res. 1995 Dec; 19(6):1578-82. PMID: 8749830.
        View in: PubMed
      115. Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. J Subst Abuse Treat. 1995 Nov-Dec; 12(6):423-8. PMID: 8749726.
        View in: PubMed
      116. George TP, Sernyak MJ, Ziedonis D, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. J Clin Psychiatry. 1995 Aug; 56(8):344-6. PMID: 7635849.
        View in: PubMed
      117. Ziedonis D, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry. 1994 Mar; 45(3):204-6. PMID: 7910577.
        View in: PubMed
      118. Leal J, Ziedonis D, Kosten T. Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence. Drug Alcohol Depend. 1994 Mar; 35(1):31-5. PMID: 8082553.
        View in: PubMed
      119. Ziedonis D, Rayford BS, Bryant KJ, Rounsaville BJ. Psychiatric comorbidity in white and African-American cocaine addicts seeking substance abuse treatment. Hosp Community Psychiatry. 1994 Jan; 45(1):43-9. PMID: 8125458.
        View in: PubMed
      120. Oliveto A, Kosten T, Schottenfeld R, Ziedonis D. Cocaine abuse among methadone-maintained patients. Am J Psychiatry. 1993 Nov; 150(11):1755. PMID: 8214197.
        View in: PubMed
      121. Schottenfeld RS, Pakes J, Ziedonis D, Kosten TR. Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans. Biol Psychiatry. 1993 Jul 1-15; 34(1-2):66-74. PMID: 8373940.
        View in: PubMed
      122. Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. J Nerv Ment Dis. 1993 Jun; 181(6):358-64. PMID: 8501457.
        View in: PubMed
      123. Kosten TR, Rosen MI, Schottenfeld R, Ziedonis D. Buprenorphine for cocaine and opiate dependence. Psychopharmacol Bull. 1992; 28(1):15-9. PMID: 1609037.
        View in: PubMed
      124. Jenkins SW, Warfield NA, Blaine JD, Cornish J, Ling W, Rosen MI, Urschel H, Wesson D, Ziedonis D. A pilot trial of gepirone vs. placebo in the treatment of cocaine dependency. Psychopharmacol Bull. 1992; 28(1):21-6. PMID: 1609038.
        View in: PubMed
      125. Ziedonis D, Richardson T, Lee E, Petrakis I, Kosten T. Adjunctive desipramine in the treatment of cocaine abusing schizophrenics. Psychopharmacol Bull. 1992; 28(3):309-14. PMID: 1480735.
        View in: PubMed
      126. Ziedonis D, Kosten TR. Pharmacotherapy improves treatment outcome in depressed cocaine addicts. J Psychoactive Drugs. 1991 Oct-Dec; 23(4):417-25. PMID: 1813613.
        View in: PubMed
      127. Ziedonis D, Kosten TR. Depression as a prognostic factor for pharmacological treatment of cocaine dependence. Psychopharmacol Bull. 1991; 27(3):337-43. PMID: 1775608.
        View in: PubMed
      128. Ziedonis D, Severs WB, Brennan RW, Page RB. Blood flow and functional responses correlate in the ovine neural lobe. Brain Res. 1986 May 14; 373(1-2):27-34. PMID: 3087575.
        View in: PubMed
      129. Townsend JB, Ziedonis D, Bryan RM, Brennan RW, Page RB. Choroid plexus blood flow: evidence for dopaminergic influence. Brain Res. 1984 Jan 02; 290(1):165-9. PMID: 6692134.
        View in: PubMed